Haleon plc ADR (NYSE: HLN) Has Another Chance To Impress You

Currently, there are 4.62B common shares owned by the public and among those 4.57B shares have been available to trade.

The company’s stock has a 5-day price change of -0.48% and 0.72% over the past three months. HLN shares are trading 1.34% year to date (YTD), with the 12-month market performance up to 3.09% higher. It has a 12-month low price of $7.70 and touched a high of $9.05 over the same period. HLN has an average intraday trading volume of 5.51 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.87%, 0.20%, and 0.39% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Institutional ownership of Haleon plc ADR (NYSE: HLN) shares accounts for 8.62% of the company’s 4.62B shares outstanding.

It has a market capitalization of $38.08B and a beta (3y monthly) value of 0.29. The stock’s trailing 12-month PE ratio is 29.69, while the earnings-per-share (ttm) stands at $0.28. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.43% over the week and 1.74% over the month.

Analysts forecast that Haleon plc ADR (HLN) will achieve an EPS of $0.11 for the current quarter, $0.09 for the next quarter and $0.51 for 2025. The lowest estimate earnings-per-share for the quarter is $0.11 while analysts give the company a high EPS estimate of $0.11. Earnings per share for the fiscal year are expected to increase by 5.44%, and 8.92% over the next financial year.

Morgan Stanley coverage for the Haleon plc ADR (HLN) stock in a research note released on November 01, 2023 offered a Overweight rating with a price target of $9. Stifel was of a view on May 24, 2023 that the stock is Hold, while Argus gave the stock Buy rating on April 06, 2023, issuing a price target of $10. Bernstein on their part issued Outperform rating on April 04, 2023.

Most Popular

Related Posts